Phase 2 study of pembrolizumab in patients with advanced rare cancers
帕博利珠单抗治疗晚期罕见癌症患者的二期研究
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2019-000347
Naing, Aung; Meric-Bernstam, Funda; Stephen, Bettzy; Karp, Daniel D; Hajjar, Joud; Rodon Ahnert, Jordi; Piha-Paul, Sarina A; Colen, Rivka R; Jimenez, Camilo; Raghav, Kanwal P; Ferrarotto, Renata; Tu, Shi-Ming; Campbell, Matthew; Wang, Linghua; Sabir, Sarjeel H; Tapia, Coya; Bernatchez, Chantale; Frumovitz, Michael; Tannir, Nizar; Ravi, Vinod; Khan, Saria; Painter, Jeane M; Abonofal, Abulrahman; Gong, Jing; Alshawa, Anas; McQuinn, Lacey M; Xu, Mingxuan; Ahmed, Sara; Subbiah, Vivek; Hong, David S; Pant, Shubham; Yap, Timothy A; Tsimberidou, Apostolia M; Dumbrava, Ecaterina E Ileana; Janku, Filip; Fu, Siqing; Simon, Richard M; Hess, Kenneth R; Varadhachary, Gauri R; Habra, Mouhammed Amir